Australia markets open in 4 hours 31 minutes

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
29.76+0.59 (+2.02%)
As of 03:29PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
67,741
67,741
180,550
169,075
133,892
Depreciation & amortisation
123,512
123,512
118,299
119,836
116,031
Deferred income taxes
-11,885
-11,885
-4,585
-2,755
-64,138
Stock-based compensation
20,143
20,143
27,725
36,210
19,590
Change in working capital
-81,574
-81,574
-39,420
18,163
-41,314
Accounts receivable
4,593
4,593
-33,905
7,265
52,105
Inventory
-59,773
-59,773
-29,124
5,374
-48,348
Accounts payable
-20,229
-20,229
17,343
32,874
-57,512
Other working capital
73,090
73,090
217,384
264,347
139,942
Other non-cash items
21,241
21,241
-10,643
8,702
31,916
Net cash provided by operating activities
139,955
139,955
264,469
312,427
203,832
Cash flows from investing activities
Investments in property, plant and equipment
-66,865
-66,865
-47,085
-48,080
-63,890
Acquisitions, net
0
0
-51,509
-303,910
0
Purchases of investments
-32,694
-32,694
0
0
-7,840
Sales/maturities of investments
1,584
5,381
4,909
76
-
Other investing activities
-64,243
-
-
-
-
Net cash used for investing activities
-94,178
-94,178
-58,580
-161,443
-68,073
Cash flows from financing activities
Debt repayment
-110,600
-110,600
-148,550
-125,500
-441,000
Common stock issued
-
-
-
-
0
Common stock repurchased
-275,000
-275,000
-125,000
0
-100,000
Other financing activities
-13,742
-13,742
-24,618
-5,050
-29,422
Net cash used provided by (used for) financing activities
-229,925
-229,925
-251,953
-98,226
121,625
Net change in cash
-180,259
-180,259
-56,787
43,282
271,255
Cash at beginning of period
456,661
456,661
513,448
470,166
198,911
Cash at end of period
276,402
276,402
456,661
513,448
470,166
Free cash flow
Operating cash flow
139,955
139,955
264,469
312,427
203,832
Capital expenditure
-66,865
-66,865
-47,085
-48,080
-63,890
Free cash flow
73,090
73,090
217,384
264,347
139,942